Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Gynecologic Oncology
|
September 1, 2009
American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction
Sarah Temin
Journal of Oncology Practice
|
May 2, 2012
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G Azzoli, Sarah Temin, Giuseppe Giaccone
JCO Oncology Practice
|
February 25, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary
Nasser H Hanna, Sarah Temin, Gregory Masters
JCO Oncology Practice
|
August 4, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guidelines Q and A
Ishmael A Jaiyesimi, Sarah Temin, Navneet Singh
Journal of Oncology Practice
|
July 11, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update Summary
Naren Ramakrishna, Sarah Temin, Nancy U Lin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Reply to B. Jeremic et al
Andrea Bezjak, Sarah Temin, Christopher G Azzoli
Journal of Oncology Practice
|
June 12, 2010
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G Azzoli, Giuseppe Giaccone, Sarah Temin
Journal of Health Communication
|
December 25, 2003
Communicating anthrax in 2001: a comparison of CDC information and print media accounts
Felicia Mebane, Sarah Temin, Claudia F Parvanta
JCO Oncology Practice
|
August 10, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update Q and A
Naren Ramakrishna, Carey K Anders, Sarah Temin
JCO Oncology Practice
|
August 10, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A
Jennie R Crews, Jeffrey J Kirshner, Sarah Temin
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Gynecologic Oncology
|
September 1, 2009
American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction
Sarah Temin
Journal of Oncology Practice
|
May 2, 2012
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G Azzoli, Sarah Temin, Giuseppe Giaccone
JCO Oncology Practice
|
February 25, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary
Nasser H Hanna, Sarah Temin, Gregory Masters
JCO Oncology Practice
|
August 4, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guidelines Q and A
Ishmael A Jaiyesimi, Sarah Temin, Navneet Singh
Journal of Oncology Practice
|
July 11, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update Summary
Naren Ramakrishna, Sarah Temin, Nancy U Lin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Reply to B. Jeremic et al
Andrea Bezjak, Sarah Temin, Christopher G Azzoli
Journal of Oncology Practice
|
June 12, 2010
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Christopher G Azzoli, Giuseppe Giaccone, Sarah Temin
Journal of Health Communication
|
December 25, 2003
Communicating anthrax in 2001: a comparison of CDC information and print media accounts
Felicia Mebane, Sarah Temin, Claudia F Parvanta
JCO Oncology Practice
|
August 10, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update Q and A
Naren Ramakrishna, Carey K Anders, Sarah Temin
JCO Oncology Practice
|
August 10, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A
Jennie R Crews, Jeffrey J Kirshner, Sarah Temin
Page
of 8